Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
investors.com/news/technology/dexcom-stock-cms-proposal-competitive-bidding-process-cgms-insulin-pumps
Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech.
The post Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-07-01 16:20:46.